Thorne Healthtech Stock Price To Book
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
Thorne HealthTech fundamentals help investors to digest information that contributes to Thorne HealthTech's financial success or failures. It also enables traders to predict the movement of Thorne Stock. The fundamental analysis module provides a way to measure Thorne HealthTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Thorne HealthTech stock.
Thorne |
Thorne HealthTech Company Price To Book Analysis
Thorne HealthTech's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Thorne HealthTech has a Price To Book of 0.0 times. This is 100.0% lower than that of the Food Products sector and 100.0% lower than that of the Consumer Staples industry. The price to book for all United States stocks is 100.0% higher than that of the company.
Thorne Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Thorne HealthTech's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Thorne HealthTech could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics of similar companies.Thorne HealthTech is currently under evaluation in price to book category among its peers.
Thorne Fundamentals
| Price To Earning | 100.20 X | |||
| Revenue | 228.73 M | |||
| EBITDA | 10.31 M | |||
| Net Income | 14.93 M | |||
| Cash And Equivalents | 27.81 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 47.03 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 2.91 X | |||
| Book Value Per Share | 2.46 X | |||
| Cash Flow From Operations | 5.22 M | |||
| Earnings Per Share | 0.15 X | |||
| Price To Earnings To Growth | 0.09 X | |||
| Target Price | 6.9 | |||
| Number Of Employees | 544 | |||
| Market Capitalization | 259.95 M | |||
| Total Asset | 229.8 M | |||
| Retained Earnings | (116.48 M) | |||
| Working Capital | 77.06 M | |||
| Z Score | 4.15 | |||
| Net Asset | 229.8 M |
About Thorne HealthTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Thorne HealthTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thorne HealthTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thorne HealthTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Thorne HealthTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.Moving against Thorne Stock
| 0.62 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.59 | BCH | Banco De Chile | PairCorr |
| 0.54 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.43 | SHG | Shinhan Financial | PairCorr |
| 0.38 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |